Peter B. Silverman, the COO & GC of $MRUS, sold 16,805 shares of the company on 07-10-2025 for an estimated $924,275. We received data on the trade from a recent SEC ...
$MRUS insiders have traded $MRUS stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales. Here’s a ...
Leerink Partners analyst Andrew Berens has maintained their bullish stance on MRUS stock, giving a Buy rating on October 16. Andrew Berens’ buy rating for Merus’s stock (MRUS) is based on several key ...
We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to take a look at where Merus N.V. (NASDAQ:MRUS) stands against other biotech ...
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 873 13F ...
Merus N.V. (NASDAQ:MRUS) and Partner Therapeutics Inc, a private biotechnology company focused on hematology and oncology, entered into an agreement in which Merus has exclusively licensed to Partner ...
We recently published a list of 10 Best Cancer Stocks to Invest in for Long-Term Gains. In this article, we are going to take a look at where Merus N.V. (NASDAQ:MRUS) stands against other best cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results